Today’s record-breaking French fine against three drugmakers drew on the experience of a related 2014 Italian fine and may face an equally arduous legal battle, the head of the French competition authority has said. Roche, Novartis and Genentech can be expected to appeal the fines totaling 444 million euros ($523 million
* = Required Field
*Areas of Interest
MLex content is primarily organized into different areas of interest that cover the main elements of regulatory risk. Please indicate which ones you would like to be included in your Daily Wrap-up alert
MLex Limited and our LexisNexis Legal & Professional group of companies will use your personal information to administer your account and/or provide the products and services that you have requested from us. We may also contact you in your professional capacity with information about our other products, services and events that we believe may be of interest. You can manage your communication preferences via our Preference Center . You can learn more about how we handle your personal data and your rights by reviewing our Privacy Policy .